. 2020 Aug 3;15:1863–1875. doi: 10.2147/COPD.S254477

Table 3.

Interventions Conducted by Pharmacists

Intervention Category	Intervention Items
A Primary prevention	A1 Smoking cessation²⁴^,²⁵^,²⁷^-³⁰^,³²^,³³^,³⁵^,³⁶^,³⁸^,³⁹^,⁴³^,⁴⁵^,⁴⁸
	A2 Lifestyle advice³⁶^,³⁸^,⁴³
B Early detection	B1 Assess patient risk and health status²⁴^,³⁵^,³⁶^,⁴⁰^,⁴¹
	B2 Self-diagnosis questionnaire²⁴^,²⁵^,³⁰^,³⁵^,³⁶^,⁴⁵^,⁴⁷
	B3 Spirometry testing²⁴^,³⁰^,³⁵^,⁴⁰^,⁴⁷
	B4 Referral/recommend high-risk customer to doctor²⁴^,³⁰^,³⁵^,³⁶^,⁴⁰^,⁴³^,⁴⁷
C Therapy management	C1 General service in pharmacy²⁵^,²⁷^-²⁹^,³¹^–³⁴^,³⁶^,³⁸^,³⁹^,⁴¹^,⁴³^,⁴⁵^,⁴⁸
	C1.1 Dispensing²⁵^,²⁹^,³⁴^,³⁸^,⁴³^,⁴⁸
	C1.2 Notification of frequency and dose²⁷^–²⁹^,³¹^–³⁴^,³⁶^,³⁸^,³⁹^,⁴¹^,⁴³^,⁴⁵^,⁴⁸
	C1.3 Notification of adherence²⁷^,²⁸^,³¹^-³⁴^,³⁸^,³⁹^,⁴¹^,⁴³^,⁴⁵^,⁴⁸
	C1.4 Notification of drug interactions²⁷^,²⁸^,³²^,³⁴^,³⁸^,⁴¹^,⁴³^,⁴⁵
	C1.5 Notification of adverse drug reactions²⁷^–²⁹^,³²^–³⁴^,³⁸^,⁴¹^,⁴³^,⁴⁵
	C1.6 Long-term monitoring of adverse drug reactions³³^,⁴³
	C2 Introduction of pathological information³¹^–³³
	C3 Assessing stage of disease³⁵^,³⁸^,³⁹^,⁴³
	C4 Inhalation technique education²⁵^,²⁶^,²⁸^,²⁹^,³¹^-³⁴^,³⁶^–³⁹^,⁴²^–⁴⁵
	C4.1 Inhalation technique short-term instruction²⁵^,²⁶^,²⁸^,²⁹^,³¹^-³⁴^,³⁶^–³⁹^,⁴²^–⁴⁵
	C4.2 Inhalation technique long-term check³¹^–³³^,⁴³^–⁴⁵
D Long-term health management	D1 Long-term follow-up and consultation²⁹^,³²^,³³^,³⁶^,³⁸^,⁴³^,⁴⁵
	D2 Prevention and treatment of exacerbations²⁹^,³¹^-³³^,³⁶^,³⁸^,³⁹^,⁴³
	D3 Influenza vaccination reminder²⁵^,³²^,³³^,⁴³^,⁴⁶^,⁴⁸
	D4 Self-care management support³²^,³³
	D5 Integrated care with other healthcare provider³²^,³⁹